The Centers for Medicare & Medicaid Services today approved for Oklahoma the first state Medicaid plan amendment to allow supplemental rebate agreements involving value-based purchasing arrangements with drug makers. The value-based agreements could produce extra rebates for the state if clinical outcomes are not achieved. “Oklahoma’s plan for value-based drug contracts is an important example of how states can innovate to bring down drug costs,” said Health and Human Services Secretary Alex Azar. In addition, CMS today approved an amendment to Massachusetts’ Section 1115(a) Medicaid demonstration, MassHealth, which permits the state to provide coverage to certain veterans and family members who receive income from state veteran annuities. Massachusetts also proposed a number of flexibilities which CMS did not approve but on which it continues to work with the state, including a request to exclude certain Medicaid-covered outpatient drugs through a closed formulary. In other news, CMS today sent a letter to states clarifying that drugs approved under section 506(c) of the Federal Food, Drug, and Cosmetic Act are covered outpatient drugs and must be covered by states consistent with the Medicaid Drug Rebate Program.

Related News Articles

Headline
The Centers for Medicare…
Headline
The Montana legislature last week passed legislation funding Medicaid coverage for low-income adults for six more years.
Headline
The Medicaid and CHIP Payment and Access Commission yesterday recommended that Congress change the definition of Medicaid shortfall to exclude costs and…
Headline
Idaho Gov. Brad Little this week signed legislation adding work requirements to the state’s plan to expand Medicaid coverage to low-income adults.
Headline
The Trump administration has appealed a federal judge’s recent ruling that blocked Medicaid work requirements in Kentucky and Arkansas.
Headline
The Senate yesterday passed by voice vote a bill (H.R. 1839) that contains a number of Medicaid provisions, including the ACE Kids Act.